GE HealthCare secures CE mark for MINItrace Magni cyclotron

GE HealthCare has secured CE Mark certification for its MINItrace Magni cyclotron and broadened its PETtrace Solid Target Platform to manufacture Copper-64. MINItrace Magni is an automated, self-shielded cyclotron developed for in-house radioisotope manufacturing. When operated alongside GE’s TRACERcenter Solutions, MINItrace Magni fits into PET radiopharmacy setups to accommodate tracer manufacturing demands. Credit: Trascenda/Shutterstock.com. GE HealthCare has secured CE Mark certification for its MINItrace Magni cyclotron and broadened its PETtrace Solid Target Platform to manufacture Copper-64. Both developments target the production infrastructure needed by healthcare institutions to run positron emission tomography (PET) programmes and pursue radiopharmaceutical research. Combine business intelligence…

Source: Medical Device Network